scholarly article | Q13442814 |
P2093 | author name string | María P Jiménez de Bagüés | |
Antoine Gross | |||
Jacques Dornand | |||
Annie Terraza | |||
P2860 | cites work | Chemokine receptors and their role in inflammation and infectious diseases | Q28144282 |
Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis | Q30839901 | ||
Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. | Q31994658 | ||
Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication | Q33591975 | ||
Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival | Q33751418 | ||
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. | Q33752010 | ||
Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence | Q34001337 | ||
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains | Q34002596 | ||
Constitutive and inducible expression of green fluorescent protein in Brucella suis. | Q34002884 | ||
Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro | Q34003056 | ||
Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes | Q34228588 | ||
Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells | Q34258360 | ||
Effects of cytokines on intracellular growth of Brucella abortus. | Q34521159 | ||
Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. | Q34546937 | ||
Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice | Q34581384 | ||
Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages | Q34714844 | ||
Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay | Q35109089 | ||
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts | Q35614226 | ||
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines | Q35773419 | ||
Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9. | Q36592150 | ||
Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines | Q36942941 | ||
Prophylaxis or treatment of experimental brucellosis with interleukin-1 | Q36963615 | ||
Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro | Q36985858 | ||
Killing of Brucella abortus by bovine serum. | Q37002576 | ||
O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophils | Q37007295 | ||
In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells | Q39513799 | ||
Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis | Q39521175 | ||
Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis | Q39741598 | ||
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides | Q39822692 | ||
Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody | Q39839146 | ||
Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortus | Q40167985 | ||
High levels of nitric oxide production decrease early but increase late survival of Brucella abortus in macrophages | Q40768344 | ||
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis. | Q40891740 | ||
Identification of the A and M antigens of Brucella as the O-polysaccharides of smooth lipopolysaccharides | Q41518824 | ||
A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. | Q47694537 | ||
Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent | Q47745245 | ||
Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors | Q47756992 | ||
Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol dependent chemiluminescence. | Q47915703 | ||
Entry and intracellular localization of Brucella spp. in Vero cells: fluorescence and electron microscopy | Q68365222 | ||
The structure of the lipopolysaccharide O-chain (M antigen) and polysaccharide B produced by Brucella melitensis 16M | Q69022088 | ||
Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovis | Q70545779 | ||
Conjugative transfer and in vitro/in vivo stability of the broad-host-range IncP R751 plasmid in Brucella spp | Q70651864 | ||
Mechanisms of binding of Brucella abortus to mononuclear phagocytes from cows naturally resistant or susceptible to brucellosis | Q72756568 | ||
Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection | Q78468297 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2429-2433 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence | |
P478 | volume | 72 |
Q93102945 | A Cellular Model of Infection with Brucella melitensis in Ovine Macrophages: Novel Insights for Intracellular Bacterial Detection |
Q58581532 | A Mutation in the Gene Alters the Physicochemical Properties of the Bacterial Cell Wall and Reduces Survival inside |
Q40203141 | A safe and molecular-tagged Brucella canis ghosts confers protection against virulent challenge in mice |
Q40607020 | Activation of bovine neutrophils by Brucella spp. |
Q30834268 | Advancement of knowledge of Brucella over the past 50 years |
Q37191746 | Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle |
Q49967391 | Brucella Lipopolysaccharide and pathogenicity: the core of the matter |
Q34601987 | Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage. |
Q38508267 | Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses |
Q91987521 | Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs |
Q42633862 | Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion |
Q34742721 | Brucella: a pathogen without classic virulence genes. |
Q36755736 | Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export |
Q33497936 | Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus |
Q47840678 | Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine |
Q44086339 | Derivation of rough attenuated variants from smooth virulent Aeromonas hydrophila and their immunogenicity in fish. |
Q44131041 | Differential expression of inflammatory and immune response genes in rams experimentally infected with a rough virulent strain of Brucella ovis |
Q37085253 | Efficient production of pronuclear embryos in breeding and nonbreeding season for generating transgenic sheep overexpressing TLR4 |
Q27334495 | Entrance and survival of Brucella pinnipedialis hooded seal strain in human macrophages and epithelial cells |
Q34995443 | Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen |
Q34721256 | Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice |
Q39985225 | Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages. |
Q40381512 | High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. |
Q38110546 | Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis |
Q35946874 | Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting |
Q52601690 | Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice. |
Q42909728 | Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. |
Q37579682 | Lon Mutant of Brucella abortus Induces Tumor Necrosis Factor-Alpha in Murine J774.A1 Macrophage |
Q38330161 | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
Q56768285 | Monocyte-derived macrophages from Zebu (Bos taurus indicus) are more efficient to control Brucella abortus intracellular survival than macrophages from European cattle (Bos taurus taurus) |
Q37592524 | Pathogenesis of bovine brucellosis. |
Q42779049 | Proinflammatory caspase-2-mediated macrophage cell death induced by a rough attenuated Brucella suis strain |
Q33883263 | Protective properties of rifampin-resistant rough mutants of Brucella melitensis |
Q33769058 | Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness. |
Q90542419 | Swine brucellosis: current perspectives |
Q40097780 | Systems Biology Analysis of Temporal In vivo Brucella melitensis and Bovine Transcriptomes Predicts host:Pathogen Protein-Protein Interactions |
Q34369289 | The evolution of chronic infection strategies in the alpha-proteobacteria. |
Q39368244 | The virB-encoded type IV secretion system is critical for establishment of infection and persistence of Brucella ovis infection in mice. |
Q33388539 | Thrombotic thrombocytopenic purpura in a case of brucellosis |
Q54217709 | Tissue distribution and cell tropism of Brucella canis in naturally infected canine foetuses and neonates. |
Q37035400 | Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. |